Skip to main content
Clinical Trials/NL-OMON46744
NL-OMON46744
Completed
Not Applicable

Self-Management And Telemedicine in patients with COPD and chronic Heart failure. - MATCH study

Medisch Spectrum Twente0 sites12 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic obstructive pulmonary disease (COPD)
Sponsor
Medisch Spectrum Twente
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 8, 2019
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- A clinical diagnosis of COPD according to the GOLD 2017 criteria (Forced Expiratory Volume in one second (FEV1\) \< 80% of the predicted value and FEV1/Vital Capacity (FVC) \< 0\.70
  • \- Chronic Heart Failure (CHF) defined according to the current (2016\) ESC guidelines
  • \- \* 2 COPD and/or CHF exacerbations\* and/or \*1 hospitalisation for COPD and/or CHF in the two years preceding study entry
  • \- \* 40 years of age
  • \- At least 1 week after prednisolone/antibiotics/furosemide course. At least 1 week after hospitalisation. At least 4 weeks post\-rehabilitation.
  • \- Able to understand and read the Dutch language
  • \- Able to use a tablet
  • \- Written informed consent from the subject prior to participation.

Exclusion Criteria

  • \- Terminal cancer or the end stage of another serious disease;
  • \- Other serious lung disease (e.g. 1\-antitrypsin deficiency; interstitial lung diseases);
  • \- Expected cardiovascular intervention within three months.
  • \- Being currently enrolled in randomized controlled trials or trial with study medication
  • \- Waiting for a heart or lung transplantation
  • \- Receiving of renal dialysis
  • \- Diabetes Mellitus type I
  • \- HADS (Hospital Anxiety and Depression Scale)\-score of \* 11 for depression and/or anxiety

Outcomes

Primary Outcomes

Not specified

Similar Trials